Results 1 to 10 of about 83,164,557 (291)

Is BMP-7 a promising diagnostic and prognostic biomarker for pediatric obstructive uropathy? [PDF]

open access: yesBMC Urology
Background Obstructive uropathy remains a major contributor to pediatric chronic kidney disease. Reliable biomarkers that predict disease progression or recovery are still lacking.
Mehdi Shirazi   +3 more
doaj   +2 more sources

BMP-7 Upregulates Id2 Through the MAPK Signaling Pathway to Improve Diabetic Tubulointerstitial Fibrosis and the Intervention of Oxymatrine [PDF]

open access: yesFrontiers in Pharmacology, 2022
Diabetic kidney disease is one of the most serious microvascular complications of diabetes. It progresses irreversibly to end-stage renal disease if left untreated. Bone morphogenetic protein (BMP)-7 is a negative regulator of organ fibrosis and may also
Yawen Xiao   +22 more
doaj   +2 more sources

BMP-7 modified exosomes derived from synovial mesenchymal stem cells attenuate osteoarthritis by M2 polarization of macrophages [PDF]

open access: yesHeliyon, 2023
Background: Although the exosomes derived from mesenchymal stem cells (MSCs) display a therapeutic effect on inflammatory diseases, its application on OA has great limitations due to lack of specificity and targeting. The current study aimed to elucidate
Weixue Sun   +4 more
doaj   +2 more sources

Sustained delivery of the bone morphogenetic proteins BMP-2 and BMP-7 for cartilage repair and regeneration in osteoarthritis [PDF]

open access: yesOsteoarthritis and Cartilage Open, 2022
Objective: Attempts to utilise growth factors (GF) such as bone morphogenic proteins (BMPs) to treat osteoarthritis (OA) in the clinic have not secured widespread adoption. However, the novel crystalline GF formulation called PODS offers new perspectives.
Ciara Whitty   +5 more
doaj   +2 more sources

Circulating BMP-7 Level is Independent of Sarcopenia in Older Asian Adults [PDF]

open access: yesAnnals of Geriatric Medicine and Research
Background In vitro and animal studies have demonstrated that bone morphogenetic protein-7 (BMP-7), renowned for its osteogenic properties, also exerts beneficial effects on muscle metabolism by enhancing myogenesis and reversing muscle atrophy.
Ahin Choi   +9 more
doaj   +2 more sources

BMP-7 ameliorates partial epithelial-mesenchymal transition by restoring SnoN protein level via Smad1/5 pathway in diabetic kidney disease [PDF]

open access: yesCell Death and Disease, 2022
Tubulointerstitial fibrosis (TIF) is involved in the development of diabetic kidney disease (DKD). Transforming growth factor β1 (TGF-β1) is involved in the extensive fibrosis of renal tissue by facilitating the partial epithelial-mesenchymal transition (
Wei Peng   +16 more
doaj   +2 more sources

BMP-7 mRNA delivered by Fibrin–CaP scaffolds activates osteogenic programs in vivo as evidenced by transcriptomic and proteomic analyses [PDF]

open access: yesBioactive Materials
Two recombinant bone morphogenetic proteins (BMP-2 and BMP-7) have received FDA approval for bone-related therapies. However, their clinical performance is limited by high costs, the need for supraphysiological doses, and adverse side effects.
Claudia Del Toro Runzer   +13 more
doaj   +2 more sources

Pediatric Pulmonary Hypertension is Associated With Increased Circulating Levels of BMP 7 and CHIP [PDF]

open access: yesPulmonary Circulation
Pulmonary arterial endothelial and smooth muscle cell homeostasis is regulated through the bone morphogenetic protein (BMP) and transforming growth factor beta (TGF‐β) receptor pathways. Pathway imbalance results in pulmonary hypertension (PH).
Edward C. Kirkpatrick   +6 more
doaj   +2 more sources

BMP-7 Treatment Increases M2 Macrophage Differentiation and Reduces Inflammation and Plaque Formation in Apo E-/- Mice. [PDF]

open access: yesPLoS ONE, 2016
Inflammation plays a fundamental role in the inception and development of atherosclerosis (ATH). Mechanisms of inflammation include the infiltration of monocytes into the injured area and subsequent differentiation into either pro-inflammatory M1 ...
Dinender K Singla   +2 more
doaj   +1 more source

Addition of bone morphogenetic protein type 2 to ascorbate and β-glycerophosphate supplementation did not enhance osteogenic differentiation of human adipose-derived stem cells

open access: yesJournal of Applied Oral Science, 2012
Bone morphogenetic protein type 2 (BMP-2) is a potent local factor, which promotes bone formation and has been used as an osteogenic supplement for mesenchymal stem cells.
Ariadne Cristiane Cabral Cruz   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy